{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:28:10Z","timestamp":1793759290787,"version":"4.6.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,12]]},"abstract":"<jats:p>\n                    Breast cancer survivors under endocrine therapy (ET) suffer from side effects such as hot flashes and sleep disturbance accompanied by poor quality of life. Many quit ET early and reduce their survival rate. Guidelines recommend gabapentin next to yoga or acupuncture. The role of side effects related to compliance with ET over years require new and effective therapies. Stellate ganglion block (SGB) has shown evidence of safety and efficacy and was found to be more effective than pregabalin without side effects. However, practical guidelines for the long-term use of SGB are still missing. We primarily used procaine instead of bupivacaine presuming effectiveness paired with lower toxic risks. Twenty-nine breast cancer survivors with severe hot flashes and sleep disturbance under ET received SGB with Procaine. Diaries recorded hot flashes and sleep quality scores up to week 24. All patients took part and none refused SGB. Each Patient received one SGB every 4 weeks without any side effects observed. Weekly scores were reduced from baseline by \u221233.6% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01) (hot flashes) and \u221222.3% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01) (sleep disturbances) after 4, and by \u221258.8% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01) (hot flashes) and \u221250.8% (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01) (sleep disturbances) after twenty-for weeks. A wavelike reduction indicated a limited effect of a single SGB during continuous ET. We showed, that procaine in SGB is as effective as bupivacaine with lower risks and costs. High significant reductions in hot flashes and sleep disturbances after 1 and 6 months were found. We conclude that breast cancer survivors need individual treatment with SGB due to her personal impact. Hence, SGB should find its way to guidelines and daily routines as a valuable method for treating side effects in breast cancer survivors undergoing ET.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000036848","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T14:59:53Z","timestamp":1705071593000},"page":"e36848","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Stellate ganglion block with procaine in breast cancer survivors with hot flashes and sleep disturbances undergoing Endocrine Therapy"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-7594","authenticated-orcid":false,"given":"Sven","family":"Soecknick","sequence":"first","affiliation":[{"name":"Neural Therapy and Acupuncture, Luebeck, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2015.64.3866","article-title":"Impact of adjuvant endocrine therapy on quality of life and symptoms: observational data over 12 Months from the Mind-Body Study.","volume":"34","author":"Ganz","year":"2016","journal-title":"J Clin Oncol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10549-011-1893-4","article-title":"Clinical and biomarker predictors of side effects from tamoxifen.","volume":"132","author":"Lorizio","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4065\/mcp.2010.0137","article-title":"Managing aromatase inhibitors in breast cancer survivors: not just for oncologists.","volume":"85","author":"Files","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000497233","article-title":"Long-term side effects of adjuvant therapy in primary breast cancer patients: results of a web-based survey.","volume":"14","author":"Haidinger","year":"2019","journal-title":"Breast Care (Basel)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2003.07.071","article-title":"Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.","volume":"21","author":"Partridge","year":"2003","journal-title":"J Clin Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1503\/cjs.006211","article-title":"Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.","volume":"57","author":"Simon","year":"2014","journal-title":"Canadian J Surg"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10549-013-2499-9","article-title":"Initiation and persistence of adjuvant endocrine therapy in a diverse sample of breast cancer patients.","volume":"38","author":"Friese","year":"2013","journal-title":"Breast Cancer Res Treatment"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.COT.0000297233.22388.3d","article-title":"Non-compliance with tamoxifen increases risk of death.","volume":"29","author":"Tuma","year":"2007","journal-title":"Oncol Times"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1089\/acm.2012.0347","article-title":"Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.","volume":"19","author":"Jeong","year":"2013","journal-title":"J Altern Complement Med"},{"key":"R13-20250504","article-title":"Pilot study of integral yoga for menopausal hot flashes.","author":"Avis","year":"2015","journal-title":"Menopause"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1985.tb03243.x","article-title":"Neuroendocrinology of menopausal flushes: a hypothesis of the flush mechanism.","volume":"22","author":"Casper","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2008.02.006","article-title":"The menopausal hot flush \u2013 anything new?","volume":"60","author":"Sturdee","year":"2008","journal-title":"Maturitas"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models.","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.mehy.2009.01.009","article-title":"A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD).","volume":"72","author":"Lipov","year":"2009","journal-title":"Med Hypotheses"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1470-2045(08)70131-1","article-title":"Effects of stellate-ganglion block on hot flushes and night awakenings in breast cancer survivors: a pilot study.","volume":"9","author":"Lipov","year":"2008","journal-title":"Lancet Oncol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.mehy.2007.01.082","article-title":"Stellate ganglion block may relieve hot flashes by interrupting the sympathetic nervous system.","volume":"69","author":"Lipov","year":"2007","journal-title":"Med Hypotheses"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.maturitas.2011.02.008","article-title":"Stellate ganglion block (SGB) to treat perimenopausal hot flashes: clinical evidence and neurobiology.","volume":"69","author":"Lipov","year":"2011","journal-title":"Maturitas"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdr478","article-title":"Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.","volume":"23","author":"Haest","year":"2012","journal-title":"Ann Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/pme.12331","article-title":"Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin.","volume":"15","author":"Othman","year":"2014","journal-title":"Pain Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0885-3924(98)00090-6","article-title":"Definitions of hot flushes in breast cancer survivors.","volume":"16","author":"Finck","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"R24-20250504","first-page":"162","article-title":"Stellate ganglion block for the treatment of hot flashes in patients with breast cancer: a literature review.","volume":"15","author":"Guirguis","year":"2015","journal-title":"Ochsner J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","article-title":"Methodologic lessons learned from hot flash studies.","volume":"19","author":"Sloan","year":"2001","journal-title":"J Clin Oncol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autneu.2016.04.002","article-title":"Effects on hemodynamic variables and echocardiographic parameters after a stellate ganglion block in 15 healthy volunteers.","volume":"197","author":"Puente de la Vega Costa","year":"2016","journal-title":"Auton Neurosci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12906-015-0735-z","article-title":"Long-term results of therapeutic local anesthesia (neural therapy) in 280 referred refractory chronic pain patients.","volume":"15","author":"Egli","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/GME.0000000000000194","article-title":"Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.","volume":"21","author":"Walega","year":"2014","journal-title":"Menopause"},{"key":"R31-20250504","first-page":"123","article-title":"Management of menopause-associated vasomotor symptoms: current treatment options, challenges and future directions.","volume":"2","author":"Pachman","year":"2010","journal-title":"Int J Women's Health"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00002508-200006000-00010","article-title":"Radiofrequency lesions of the stellate ganglion in chronic pain syndromes: retrospective analysis of clinical efficacy in 86 patients.","volume":"16","author":"Forouzanfar","year":"2000","journal-title":"Clin J Pain"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1470-2045(08)70135-9","article-title":"Stellate-ganglion block: a new treatment for hot flushes?","volume":"9","author":"Loprinzi","year":"2008","journal-title":"Lancet Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:14:33Z","timestamp":1746314073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036848","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}